Clinical Trials Directory

Trials / Completed

CompletedNCT05944484

Effect of Visceral vs Total Body Fat Reduction in Obese Female With Stress Urinary Incontinence

Effect of Visceral vs Total Body Fat Reduction in Obese Female With Stress Urinary Incontinence by EMG and Iciq Questionnaire

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Dina Mohamed Tarek Mansour El-kasrawy · Academic / Other
Sex
Female
Age
35 Years – 48 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the visceral fat reduction versus total body fat reduction on stress urinary incontinence in obese females.

Detailed description

compare the effect of visceral fat reduction versus total body fat reduction on stress urinary incontinence in obese females. control group: consist of 20 obese women. They will receive Kegel exercises only 3 session/ week for 12 weeks. Diet group: consist of 20 obese women. They will receive low caloric diet and Kegel exercises 3 session/week for 12 weeks. Ultrasound cavitation group: consist of 20 obese women. They will receive Kegel exercises 3 session/week and ultrasound cavitation two sessions per week.

Conditions

Interventions

TypeNameDescription
BEHAVIORALlow caloric diet, ultrasound cavitation,Kegel exercises* low caloric diet (800-1200) calories/day,). According to each patient, diet contained (carbohydrate protein, fats, minerals, vitamins). 50 to 55% of total calories are carbohydrates, 10 to 15% of total calories protein. Fat limited to less than about 28% of daily total calories .Women took 1200 calories in the first month, 1000 calories in the second month, and 800 calories in the third month. Every week, each woman allowed to change the types of food to avoid boarding. * ultrasound cavitation emits low-frequency ultrasound 40 khz for 30 minutes on abdomen twice/ week with 3 days apart for 12 weeks. kegel exercise: Each woman in the study took the same Kegel exercise program performed the Kegel exercise for 12 weeks (3 sessions per week)

Timeline

Start date
2020-11-30
Primary completion
2023-05-05
Completion
2023-06-05
First posted
2023-07-13
Last updated
2023-07-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05944484. Inclusion in this directory is not an endorsement.